<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/49</identifier>
				<datestamp>2022-06-28T18:58:42Z</datestamp>
				<setSpec>aavptbiennial:S1</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Novel Uses of in Vivo Ultrafiltration for Pre-Clinical Pharmacokinetic Studies in Animals</dc:title>
	<dc:creator xml:lang="en">Messenger, Kristen</dc:creator>
	<dc:subject xml:lang="en">in vivo ultrafiltration</dc:subject>
	<dc:subject xml:lang="en">drug pharmacokinetics</dc:subject>
	<dc:subject xml:lang="en">drug pharmacodynamics</dc:subject>
	<dc:subject xml:lang="en">antimicrobial concentration</dc:subject>
	<dc:description xml:lang="en">We have successfully combed in vivo ultrafiltration methodology with previously established inflammatory models (carrageenan) may to study both drug pharmacokinetics and pharmacodynamics directly at effect sites in the body (Messenger et al., 2016), and more recently in naturally occurring surgical models to study the anti-inflammatory effects of different analgesic drugs (Southern et al., 2019). Other investigators in our laboratory have applied this methodology to study antimicrobial concentrations in the GI tract of cattle (Warren et al., 2014; Foster et al., 2016; Ferguson et al., 2018) as well as in the teat cistern of dairy cattle (Mzyk et al., 2018). Our most recent work includes the use of ultrafiltration probes into different segments of the intestinal lumen to quantify locally-acting peptide drugs and their fragments once exposed to peptidases in the GI tract.
&amp;nbsp;
This presentation will review background, scientific and technical aspects of in vivo ultrafiltration, discuss troubleshooting, and lastly, will present some of the unique experiments where our laboratory has applied this methodology.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>2019-08-23</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/49</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; 21st Biennial Symposium; 17-20</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/49/43</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2019 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
